Letter to the Editor Regarding Esophageal Dysfunction and Systemic Sclerosis: Drugs Should be Kept in Mind

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/55357

Title:	Letter to the Editor Regarding Esophageal Dysfunction and Systemic Sclerosis: Drugs Should be Kept in Mind
Authors:	BERNAL-BELLO, DAVID Serantes-Gómez, David Izquierdo Martínez, Aída Morales-Ortega, Alejandro Duarte Millan, Miguel Angel Frutos Pérez, Begoña View more
Filiation:	Servicio de Medicina Interna. Hospital Universitario de Fuenlabrada.
Keywords:	Barrett’s esophagus Drugs Esophageal adenocarcinoma Esophageal dysfunction Gastroesophageal reflux disease Scleroderma Systemic sclerosis Therapy View more
Mesh:	Barrett Esophagus Esophageal Neoplasms Scleroderma, Systemic Drug Therapy View more
Decs:	Esclerodermia Sistémica Esófago de Barrett Neoplasias Esofágicas /tratamiento farmacológico View more
Issue Date:	18-Jun-2022
Publisher:	Springer Science and Business Media LLC
Citation:	Bernal-Bello D, Serantes-Gómez D, Izquierdo-Martínez A, Morales-Ortega A, Duarte-Millán MÁ, Frutos-Pérez B. Letter to the Editor Regarding Esophageal Dysfunction and Systemic Sclerosis: Drugs Should be Kept in Mind. Rheumatol Ther. 2022 Aug;9(4):1237-1240. doi: 10.1007/s40744-022-00459-4. Epub 2022 Jun 18. PMID: 35716236; PMCID: PMC9314470.
PMID:	35716236
URI:	https://hdl.handle.net/20.500.12530/55357
Rights:	info:eu-repo/semantics/openAccess Atribución-NoComercial-CompartirIgual 3.0 España
Appears in Collections:	Hospitales > H. U. de Fuenlabrada > Artículos

Files in This Item:

File	Description	Size	Format
s40744-022-00459-4.pdf		200.03 kB	Adobe PDF	View/Open

This item is licensed under a Creative Commons License